Medindia

X

A New Era Dawns in Cancer Treatment: Members of the Media Are Invited To Attend Decision Resources' Analyst Call Regarding The U.S. Approval of Provenge for Prostate Cancer

Monday, May 3, 2010 General News J E 4
Advertisement
Provenge's Approval, Which Had Been Forecasted By Decision Resources Nearly a Decade Ago Despite Skepticism, Marks a Crucial Turning Point in the Potential of Therapeutic Vaccines in Oncology

For more information, contact:

Christopher Comfort

781-296-2597

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Survey Finds Workers View Protecting Valuable Poss...
S
SynCo Expands Agreement with OncoMed Pharmaceutica...